New-onset diabetes mellitus among patients with glomerular diseases.

Background: Glomerulonephritis commonly causes kidney failure. Immunosuppressant treatment may be diabetogenic, but data on hyperglycaemia in glomerulonephritis treated with usual clinical care are scant.

Aim: To assess the epidemiology, risk factors and outcomes for new-onset diabetes among patients with glomerular disease (NODAG).